Literature DB >> 8149945

Kinetics of propiverine as assessed by radioreceptor assay in poor and extensive metabolizers of debrisoquine.

C Müller1, W Siegmund, R Huupponen, T Kaila, G Franke, E Iisalo, M Zschiesche.   

Abstract

A pharmacokinetic study with 30 mg propiverine p.o. was performed in healthy volunteers (10 males, 6 females, age 36-56 years, body weight 55-100 kg, body height 162-184 cm, Broca index 0.96-1.19). 8 of them were poor and 8 extensive metabolizers of the debrisoquine type hydroxylation polymorphism. The total anticholinergic activity of the parent compound and active metabolites was measured with a radioreceptor assay calibrated with the metabolite M2. The affinity of this metabolite to the muscarinic receptors was similar to that of atropine. The urinary excretion of 3 major metabolites was determined with TLC and densitometry. Arterial blood pressure, heart rate, diameter of pupils, accommodation and parotic salivary flow were also measured. The concentrations of anticholinergic equivalents of propiverine were below 1 ng/ml of M2. 1.4-6.0% of the dose were excreted as N-oxidized metabolites into the urine. The poor and extensive metabolizers of debrisoquine did not differ significantly with regard to the concentration time behaviour of the active drug components, pattern of major metabolites, adverse drug reactions or any pharmacodynamic parameters measured.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8149945     DOI: 10.1007/BF03188807

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  26 in total

1.  N-acetylation and debrisoquine type oxidation polymorphism in Caucasians--with reference to age and sex.

Authors:  W Siegmund; W Hanke; M Zschiesche; G Franke; K E Biebler; A Wilke
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1990-12

2.  [Effects of propiverine hydrochloride and its metabolites on isolated guinea pig urinary bladder].

Authors:  A Haruno; Y Yamasaki; K Miyoshi; H Miyake; K Tsuchiya; M Kosaka; M Nagai; M Iriki
Journal:  Nihon Yakurigaku Zasshi       Date:  1989-08

3.  [Mode of inhibitory action of propiverine hydrochloride on the micturition movements of the bladder in dogs].

Authors:  S Kaneko; K Kitazato; Y Yamazaki; H Okada
Journal:  Nihon Yakurigaku Zasshi       Date:  1989-08

4.  [The spasmolytic activity of propiverine and some of its structural analogs].

Authors:  J Riotte; E Mutschler
Journal:  Arzneimittelforschung       Date:  1987-03

5.  [Treatment of the unstable bladder in children with the anticholinergic agent propiverin hydrochloride (mictonorm/mictonets)].

Authors:  G Otto-Unger
Journal:  Z Urol Nephrol       Date:  1985-03

6.  [Treatment of the symptoms of urinary urge and urge incontinence with propiverin hydrochloride (Mictonorm)].

Authors:  U Blau; U Retzke
Journal:  Zentralbl Gynakol       Date:  1984

7.  Gas chromatographic-mass fragmentographic determination of propiverine and its metabolites in plasma and urine.

Authors:  T Marunaka; Y Umeno; Y Minami; E Matsushima; M Maniwa; K Yoshida; M Nagamachi
Journal:  J Chromatogr       Date:  1987-09-04

8.  [Effect of propiverine hydrochloride on the function of the bladder in decerebrated dogs].

Authors:  S Kaneko; K Kitazato; Y Yamazaki; H Okada; M Nagai; M Iriki
Journal:  Nihon Yakurigaku Zasshi       Date:  1990-02

9.  Studies on the metabolic pattern of propiverine in urine after single administration.

Authors:  G Hüller; K O Haustein; S Scheithauer
Journal:  Pharmazie       Date:  1988-02       Impact factor: 1.267

10.  [The biotransformation of propiverin hydrochloride (Mictonorm)].

Authors:  B Göber; K Dressler; P Franke
Journal:  Pharmazie       Date:  1988-02       Impact factor: 1.267

View more
  4 in total

Review 1.  Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?

Authors:  Martin C Michel; Sharath S Hegde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11       Impact factor: 3.000

Review 2.  [Overactive bladder--treatment with antimuscarinic agents].

Authors:  K Höfner
Journal:  Urologe A       Date:  2003-05-20       Impact factor: 0.639

Review 3.  Clinical pharmacokinetics of drugs used to treat urge incontinence.

Authors:  David R P Guay
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  The Impact of Gene Polymorphisms on the Success of Anticholinergic Treatment in Children with Overactive Bladder.

Authors:  Serhat Gurocak; Ece Konac; Iyimser Ure; Cem Senol; Ilke Hacer Onen; Sinan Sozen; Adnan Menevse
Journal:  Dis Markers       Date:  2015-06-24       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.